SHEENA BROWN: Open Payments
NPI 1932811437 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 39 payments from 14 companies in 2025. Trend: 2023 $1,695 · 2024 $1,283 · 2025 $796
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $167 |
| Vanda Pharmaceuticals Inc. | 3 | $103 |
| Almatica Pharma LLC | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Alkermes, Inc. | 3 | $60 |
| Sage Therapeutics, LLC | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Lundbeck LLC | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $33 |
Products named: VRAYLAR, REXULTI, FANAPT, LOREEV XR, ZURZUVAE, AUSTEDO XR, ARISTADA, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
